Cyclin G1 is one of the target genes of the transcription factor p53, and is induced in a p53-dependent manner in response to DNA damage. Although cyclin G1 has been implicated in a range of ...

David leads the editorial team at CNET. We create expert reviews, articles and video on every aspect of technology, from AI to Zoox. We are thoroughly, proudly human. Expertise A 25-year CNET veteran, ...

- Business Combination Expected to Provide Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC) Optimal Access to G1’s COSELA® (trilaciclib), the First and Only Proactive Multilineage ...

Even Realities, a company that blends digital and physical realities, announced the launch of its first product, the G1 Digital Glasses. The Berlin, Germany-based company said the G1 marks a ...

As Pharmacosmos Therapeutics looks to enter the oncology market, the company has entered into a definitive merger agreement with G1 Therapeutics, with the former’s US subsidiary acquiring all ...

G1 Therapeutics steered a first-of-its-kind lung cancer drug to FDA approval, but long maintained that development and commercialization globally would require partnerships. There’s a new path forward ...

The G1 Climax 27, New Japan Pro Wrestling's annual tournament showcase pitting 20 of their best heavyweights against each other in a month-long round-robin format, has crossed its halfway point. As is ...

Gabe Kidd withdrew from night two of G1 Climax 35, but hopes to return and finish the tournament. Taichi defeated Yuya Uemura in a clash of teacher versus student. Night two of G1 Climax 35 started on ...